Abstract
Age-related macular degeneration is a common cause of visual loss. There may be choroidal neovascularisation or geographic atrophy. Evidence is accumulating for the importance of avoidable risk factors in age-related macular degeneration, such as smoking and obesity. Research confirms that there is an important hereditary component to the disease. Anti-vascular endothelial growth factors have improved the outlook for patients suffering from neovascular age-related macular degeneration. Recent work has concentrated on refining the frequency and pattern of delivery of these drugs to the vitreous cavity. There are few treatment options forgeographic atrophy.
| Original language | English |
|---|---|
| Pages (from-to) | 90-93 |
| Number of pages | 4 |
| Journal | Australian Prescriber |
| Volume | 35 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2012 |
| Externally published | Yes |
Keywords
- Anti-vascular endothelial growth factor
- Bevacizumab
- Choroidal neovascularisation
- Ranibizumab
